Answers are grounded in this paper and cite their sources.
Bacterial resistance is addressed clinically by combining a β-lactamase inhibitors with a β-lactam antibiotic. Whereas this strategy is effective with the class A β-lactamase inhibitors, there is an urgent need to extend the spectrum of activity to the other classes of serine β-lactamases. Interaction energies and modeling studies on penem inhibitors described herein, show that β-lactamases of the different classes prefer different stereochemistries.
No takes yet. Share an insight, caveat, or question.
Mansour et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: